{"id":"W7116856447","doi":"10.1016/j.annonc.2025.10.1100","title":"663TiP BNT323-01: A phase III trial of trastuzumab pamirtecan (HER2 ADC) versus investigator’s choice of chemotherapy in pretreated patients with HER2-expressing recurrent endometrial cancer (EC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. John’s Health Sciences Centre","funders":"","keywords":"Chemotherapy; Trastuzumab; Endometrial cancer; Phases of clinical research; Chemotherapy regimen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001098071,0.001002159,0.00130798,0.000301305,0.0002672911,0.0007691361,0.0006699364,0.001094587,0.006098276],"category_scores_gemma":[0.000858449,0.0004555477,0.001060136,0.0003641178,0.0007704565,0.0007528163,0.0003161396,0.003452536,0.001015858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007733934,"about_ca_system_score_gemma":0.001061247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001626783,"about_ca_topic_score_gemma":0.005346285,"domain_scores_codex":[0.999762,0.0001124149,0.00001039256,0.00003658935,0.00001532997,0.00006330737],"domain_scores_gemma":[0.9996417,0.00007174013,0.00005789565,0.00002674765,0.00001240391,0.0001895091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8248027,0.02278709,0.003564678,0.0006124466,0.001106932,0.0001419553,0.00024553,0.003430402,0.01350263,0.0005490365,0.004823458,0.1244331],"study_design_scores_gemma":[0.7282849,0.2552157,0.007256454,0.000057868,0.0005488254,0.000182237,0.00008964456,0.002577017,0.001709438,0.000540258,0.00350047,0.00003714121],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921151,0.00196981,0.000310662,0.0009692015,0.0002365546,0.0006808215,0.0007872882,0.00009901611,0.002831583],"genre_scores_gemma":[0.9888377,0.001905603,0.001207192,0.001181885,0.0001551201,0.0008472059,0.001708871,0.00003492937,0.00412142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006098276,"threshold_uncertainty_score":0.02040076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08636840016573863,"score_gpt":0.4216284111288951,"score_spread":0.3352600109631565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}